Comparison of a new PillCam™ SB2 video capsule versus the standard PillCam™ SB for detection of small bowel disease
Yoav C Metzger1, Samuel N Adler2, Ariella Bar-Gil Shitrit3, Binyamin Koslowsky4, Ingvar Bjarnason5
1School of Medicine, Hebrew University of Jerusalem, Israel; 2Department of Gastroenterology, Bikur Holim Hospital, Jerusalem, Israel; 3Department of Gastroenterology, Shaare Zedek Medical Center, Jerusalem, Israel; 4Department of Medicine, Hadassah Medical Organization, Jerusalem, Israel; 5Department of Gastroenterology, King’s College Hospital, London, UK
Background: Capsule endoscopy is the procedure of choice for many suspected small bowel diseases. PillCam™ small bowel (SB), has a high diagnostic yield. No improvements have been made on its optics since its introduction in 2002.
Aim: To compare the diagnostic yield and quality of visualization of PillCam™ SB with that of a new small bowel endoscope (PillCam™ SB2) which has a larger angle of view and upgraded visual attributes.
Methods: Twenty patients were randomized to undergo capsule enteroscopy with PillCam™ SB and PillCam™ SB2 a week apart.
Results: Both procedures had a comparable diagnostic yield. However images from PillCam™ SB2 were found to be significantly better in regards of homogenous light exposure (P < 0.001), sharpness and resolution (P < 0.001), depth of view (P < 0.005), and overall impression (P < 0.0001).
Conclusion: PillCam™ SB2 appears to be superior to the original PillCam™ SB in regard to quality of images obtained.
Keywords: small bowel, capsule endoscopy, image quality, resolution
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]
Readers of this article also read:
Effects of zinc oxide nanoparticles on Kupffer cell phagosomal motility, bacterial clearance, and liver function
Watson CY, Molina RM, Louzada A, Murdaugh KM, Donaghey TC, Brain JD
Published Date: 26 June 2015
Upconversion nanoparticle-mediated photodynamic therapy induces THP-1 macrophage apoptosis via ROS bursts and activation of the mitochondrial caspase pathway
Zhu X, Wang H, Zheng LB, Zhong ZY, Li XS, Zhao J, Kou JY, Jiang YQ, Zheng XF, Liu ZN, Li HX, Cao WW, Tian Y, Wang Y, Yang LM
Published Date: 22 May 2015
Strategies to improve physical activity by exercise training in patients with chronic kidney disease
Morishita Y, Nagata D
Published Date: 10 March 2015
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles
Cabeza L, Ortiz R, Arias JL, Prados J, Ruiz Martinez MA, Entrena JM, Luque R, Melguizo C
Published Date: 13 February 2015
Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery
Vasconcelos A, Vega E, PΓ©rez Y, GΓ³mara MJ, GarcΓa ML, Haro I
Published Date: 27 January 2015
Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study
Braz JΓΊnior DS, Dornelas de Andrade A, Teixeira AS, Cavalcanti CA, Morais AB, Marinho PE
Published Date: 12 January 2015
Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies
Zwikker HE, van den Bemt BJ, Vriezekolk JE, van den Ende CH, van Dulmen S
Published Date: 25 April 2014
Locke JE, Singer AL
Published Date: 13 May 2011
Edmund Soh, Kenneth Sheah, Keh Oon Ong
Published Date: 14 February 2011
Published Date: 26 August 2010